News | October 16, 2024
Akums Drugs enters into license and distribution agreement with Triple Hair, Canada
Akums Drugs will undertake this development and commercialization in India
Akums Drugs will undertake this development and commercialization in India
Developed in consultation with clinicians and patients for an enhanced user experience
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Winrevair is the first activin signaling inhibitor therapy for PAH approved in Europe
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
WINREVAIR is a breakthrough biologic for this rare, progressive disease
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
We are achieving the target of developed India by making our young children healthy today
Subscribe To Our Newsletter & Stay Updated
